Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases
Go back to Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1137.82 +1.71 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1136.11 | 52 Week High | $88.16 | |||
| Open | $1137.31 | 52 Week Low | $67.88 | |||
| Day High | $1151.23 | P/E | 263.38 | |||
| Day Low | $1132.63 | EPS | $4.32 | |||
| Volume | 1,476,138 | |||||
